⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL228542 | 1.00 | — | — | |
| SCHEMBL9773626 | 0.83 | TDP1 (0.31) | — | |
| SCHEMBL3221896 | 0.79 | — | — | |
| SCHEMBL367396 | 0.79 | — | — | |
| SCHEMBL3652169 | 0.79 | ALDH1A1 (0.38) | — | |
| SCHEMBL5705571 | 0.78 | ZDHHC20 (0.33) | — | |
| SCHEMBL16660 | 0.77 | — | — | |
| SCHEMBL419451 | 0.77 | — | — | |
| SCHEMBL5831469 | 0.75 | EP300 (0.47) | — | |
| SCHEMBL1255448 | 0.75 | EP300 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2760917-A1 | SILICONE HYDROGELS HAVING IMPROVED CURING SPEED AND OTHER PROPERTIES | Johnson & Johnson Vision Care Inc. (US) | 2014-08-06 | — | — | EP | claimed |
| WO-2013048990-A1 | SILICONE HYDROGELS HAVING IMPROVED CURING SPEED AND OTHER PROPERTIES | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2013-04-04 | — | — | WO | claimed |
| US-11834547-B2 | Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| CN-109666121-B | Hybrid dynamic cross-linked polymer and application thereof | 厦门逍扬运动科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-4204513-A1 | METHOD FOR CONTROLLING THE MIGRATION OF FORMATION FINES | Poweltec (FR) | 2023-07-05 | — | — | EP | disclosed |
| WO-2022043055-A1 | METHOD FOR CONTROLLING THE MIGRATION OF FORMATION FINES | POWELTEC (FR) | 2022-03-03 | — | — | WO | disclosed |
| US-20210179766-A1 | OPHTHALMIC DEVICES DERIVED FROM GRAFTED POLYMERIC NETWORKS AND PROCESSES FOR THEIR PREPARATION AND USE | JOHNSON & JOHNSON VISION CARE (US) | 2021-06-17 | — | — | US | disclosed |
| EP-3759148-A1 | POLYMER PARTICLES WITH A GRADIENT COMPOSITION AND METHODS OF PRODUCTION THEREOF | Waters Technologies Corporation (US) | 2021-01-06 | — | — | EP | disclosed |
| EP-3494168-A1 | POLYMER COMPOSITIONS CONTAINING GRAFTED POLYMERIC NETWORKS AND PROCESSES FOR THEIR PREPARATION AND USE | Johnson & Johnson Vision Care Inc. (US) | 2019-06-12 | — | — | EP | disclosed |
| WO-2018026822-A1 | POLYMER COMPOSITIONS CONTAINING GRAFTED POLYMERIC NETWORKS AND PROCESSES FOR THEIR PREPARATION AND USE | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2018-02-08 | — | — | WO | disclosed |
| EP-3277845-A1 | BEADS FOR NUCLEIC ACID SEQUENCING | Genapsys Inc. (US) | 2018-02-07 | — | — | EP | disclosed |
| US-7919117-B2 | Drug delivery of fesoterodine (fumarate) through the skin in a dosage ofo.r-20 mg per day and is provided in a polymer matrix for uniform release;contact adhesives; sel-adhesives; impermeable backing; flatness; geratrics;drug delivery; side effect reduction | UCB PHARMA GMBH (DE) | 2011-04-05 | — | — | US | disclosed |
| WO-2010055162-A1 | ENANTIOSELECTIVE SYNTHESIS OF γ-AMINO-α,β-UNSATURATED CARBOXYLIC ACID DERIVATIVES | NOVARTIS AG (CH) | 2010-05-20 | — | — | WO | disclosed |
| US-7670621-B2 | Transdermal administration of (R)-3,3-diphenylpropylamin-monoesters | SCHWARZ PHARMA AG (DE) | 2010-03-02 | — | — | US | disclosed |
| US-20090274761-A1 | TRANSDERMAL DELIVERY OF (R)-3,3-DIPHENYLPROPYLAMIN-MONOESTERN | SCHWARZ PHARMA AG (DE) | 2009-11-05 | — | — | US | disclosed |
| US-20090012159-A1 | HIGH PURITY BASES OF 3,3-DIPHENYLPROPYLAMINO MONOESTERS | UCB PHARMA GMBH (DE) | 2009-01-08 | — | — | US | disclosed |
| US-20060029673-A1 | Transdermal administration of (r)-3,3-diphenylpropylamin-monoesters | SCHWARZ PHARMA AG (DE) | 2006-02-09 | — | — | US | disclosed |
| US-20060014832-A1 | Highly pure bases of 3,3-dipheyl propylamine monoesters | SCHWARZ PHARMA AG (DE) | 2006-01-19 | — | — | US | disclosed |
| US-4676911-A | ACRYLIC AMIDE SULFATE, ACRYLIC ACID COPOLYMERS | NALCO CHEMICAL COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
| US-3954863-A | Synthesis, polymerization and quaternization of N-substituted acrylamidines | UNION CARBIDE CORPORATION (US) | 1976-05-04 | — | — | US | disclosed |